Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-027275
Filing Date
2022-08-01
Accepted
2022-08-01 21:18:15
Documents
2
Period of Report
2022-08-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4138
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3496
  Complete submission text file 0000899243-22-027275.txt   9032
Mailing Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Magenta Therapeutics, Inc. (Issuer) CIK: 0001690585 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MAGENTA THERAPEUTICS, INC. 100 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address
Olson Lisa (Reporting) CIK: 0001824009 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38541 | Film No.: 221126627